Control of adipogenic commitment by a STAT3-VSTM2A axis.

Manal Al Dow, Maruhen Amir Datsch Silveira, Audrée Poliquin, Laura Tribouillard, Éric Fournier, Eva Trébaol, Blandine Secco, Romain Villot, Félix Tremblay, Steve Bilodeau, Mathieu Laplante

American journal of physiology. Endocrinology and metabolism 2021 Feb 01

filter terms:

White adipose tissue (WAT) is a dynamic organ that plays crucial roles in controlling metabolic homeostasis. During development and periods of energy excess, adipose progenitors are recruited and differentiate into adipocytes to promote lipid storage capability. The identity of adipose progenitors and the signals that promote their recruitment are still incompletely characterized. We have recently identified V-set and transmembrane domain-containing protein 2A (VSTM2A) as a novel protein enriched in preadipocytes that amplifies adipogenic commitment. Despite the emerging role of VSTM2A in promoting adipogenesis, the molecular mechanisms regulating Vstm2a expression in preadipocytes are still unknown. To define the molecular mechanisms controlling Vstm2a expression, we have treated preadipocytes with an array of compounds capable of modulating established regulators of adipogenesis. Here, we report that Vstm2a expression is positively regulated by PI3K/mTOR and cAMP-dependent signaling pathways and repressed by the MAPK pathway and the glucocorticoid receptor. By integrating the impact of all the molecules tested, we identified signal transducer and activator of transcription 3 (STAT3) as a novel downstream transcription factor affecting Vstm2a expression. We show that activation of STAT3 increased Vstm2a expression, whereas its inhibition repressed this process. In mice, we found that STAT3 phosphorylation is elevated in the early phases of WAT development, an effect that strongly associates with Vstm2a expression. Our findings identify STAT3 as a key transcription factor regulating Vstm2a expression in preadipocytes.NEW & NOTEWORTHY cAMP-dependent and PI3K-mTOR signaling pathways promote the expression of Vstm2a. STAT3 is a key transcription factor that controls Vstm2a expression in preadipocytes. STAT3 is activated in the early phases of WAT development, an effect that strongly associates with Vstm2a expression.

Citation

Manal Al Dow, Maruhen Amir Datsch Silveira, Audrée Poliquin, Laura Tribouillard, Éric Fournier, Eva Trébaol, Blandine Secco, Romain Villot, Félix Tremblay, Steve Bilodeau, Mathieu Laplante. Control of adipogenic commitment by a STAT3-VSTM2A axis. American journal of physiology. Endocrinology and metabolism. 2021 Feb 01;320(2):E259-E269